What is SubjectWell?
SubjectWell is dedicated to raising awareness of clinical research within the general population, aiming to provide patients with greater choice and accessible entry points to innovative treatment options. The company's platform serves as a crucial bridge between patients seeking novel therapies and researchers conducting clinical trials, thereby accelerating the pace of medical advancement. By simplifying patient recruitment and increasing visibility for research opportunities, SubjectWell plays a vital role in the healthcare ecosystem.
How much funding has SubjectWell raised?
SubjectWell has raised a total of $45.9M across 4 funding rounds:
Series A
$10M
Debt
$350K
Debt
$542K
Series B
$35M
Series A (2019): $10M with participation from Windham Venture Partners, Geekdom Fund, and Healthy Ventures
Debt (2020): $350K led by PPP
Debt (2021): $542K supported by PPP
Series B (2022): $35M featuring Geekdom Fund, Bertelsmann SE, Healthy Ventures, Venture Asset Management, and Windham Venture Partners
Key Investors in SubjectWell
Windham Venture Partners
Windham Venture Partners is a New York City based venture capital firm focused on healthcare, with particular emphasis on medical technology and digital health. They maintain close relationships with strategics, leading venture capital firms, and innovators in the healthcare industry.
Geekdom Fund
Geekdom Fund is a venture capital firm dedicated to connecting entrepreneurs with investors, providing significant support and resources to portfolio companies. They focus on delivering results and have a track record of helping companies raise funding at a rate three times higher than the industry average.
Healthy Ventures
Healthy Ventures is a purpose-built, early-stage venture investor focused on health tech, aiming to support the scaling and diversification of healthcare technologies. They invest in health tech founders, providing resources and a robust network to accelerate market adoption.
What's next for SubjectWell?
With the recent major strategic investment, SubjectWell is poised for accelerated growth and market penetration. The company is expected to leverage this capital to further develop its platform, expand its network of healthcare providers and research institutions, and enhance its patient outreach initiatives. The strategic nature of this funding suggests a focus on strengthening partnerships and solidifying its position as a leader in the clinical trials marketplace, ultimately driving greater participation in research and faster access to new treatments.
See full SubjectWell company page
